Effects of C-4 Stereochemistry and C-4‘ Hydroxylation on the Iron Clearing Efficiency and Toxicity of Desferrithiocin Analogues
- 12 June 1999
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 42 (13) , 2432-2440
- https://doi.org/10.1021/jm990058s
Abstract
Additional structure−activity studies of desferrithiocin analogues are carried out. The effects of stereochemistry at C-4 on the ligands' iron clearing efficiency are reviewed and assessed using the enantiomers 4,5-dihydro-2-(2,4-dihydroxyphenyl)thiazole-4(R)-carboxylic acid and 4,5-dihydro-2-(2,4-dihydroxyphenyl)thiazole-4(S)-carboxylic acid. The utility of 4‘-hydroxylation as a method of reducing the toxicity of desazadesferrithiocin analogues is also examined further with the synthesis and in vivo comparison of 4,5-dihydro-2-(2-hydroxyphenyl)-4-methylthiazole-4(S)-carboxylic acid, which is the natural product 4-methylaeruginoic acid, and 4,5-dihydro-2-(2,4-dihydroxyphenyl)-4-methylthiazole-4(S)-carboxylic acid. The stereochemistry at C-4 is shown to have a substantial effect on the iron clearing efficiency of desferrithiocin analogues, as does C-4‘-hydroxylation on the toxicity profile. All of the compounds are evaluated in a bile-duct-cannulated rodent model to determine iron clearance efficiency and are carried forward to the iron-overloaded primate for iron clearing measurements. On the basis of the results of the present work, although 4,5-dihydro-2-(2,4-dihydroxyphenyl)thiazole-4(S)-carboxylic acid is still the most promising candidate for clinical evaluation, 4,5-dihydro-2-(2,4-dihydroxyphenyl)-4-methylthiazole-4(S)-carboxylic acid (4‘-hydroxydesazadesferrithiocin) also merits further preclinical assessment.Keywords
This publication has 13 references indexed in Scilit:
- The Origin of the Differences in (R)‐ and (S)‐Desmethyldesferrithiocin: Iron‐Clearing PropertiesaAnnals of the New York Academy of Sciences, 1998
- A comparative study of the iron-clearing properties of desferrithiocin analogues with desferrioxamine B in a Cebus monkey modelBlood, 1993
- A comparison of the iron-clearing properties of 1,2-dimethyl-3- hydroxypyrid-4-one, 1,2-diethyl-3-hydroxypyrid-4-one, and deferoxamineBlood, 1992
- A Comparative Evaluation of Iron Clearance ModelsAnnals of the New York Academy of Sciences, 1990
- Synthesis and solution structure of microbial siderophoresChemical Reviews, 1984
- THE MANAGEMENT OF IRON CHELATION THERAPYBritish Journal of Haematology, 1983
- Microbial Iron CompoundsAnnual Review of Biochemistry, 1981
- Coordination chemistry and microbial iron transportAccounts of Chemical Research, 1979
- Chelation therapy in β-thalassemia major. I. Intravenous and subcutaneous deferoxamineThe Journal of Pediatrics, 1978
- Continuous Subcutaneous Administration of Deferoxamine in Patients with Iron OverloadNew England Journal of Medicine, 1977